The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats

Gabriella Joó, G. Horváth, Walter Klimscha, G. Kékesi, I. Dobos, Margit Szikszay, G. Benedek

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Background: The spinal administration of some N-methyl-D-aspartate receptor antagonists results in antinociception and potentiates the effects of opioids and α 2-adrenoceptor agonists, but ketamine and its enantiomers have not been examined. The present study investigated the interactions of racemic ketamine, R(-)-ketamine and S(+)-ketamine with morphine and with dexmedetomidine. Methods: Intrathecal catheters were implanted into male Wistar rats. Three days later, the acute nociceptive sensitivity was assessed using the tail-flick test. Analgesic latencies were converted to the percentage maximum possible effect. The dose that yielded 50% of the maximum possible effect (ED 50) and dose-response and time-course curves were determined for the ketamines (30-300 μg), morphine (0.13.0 μg), dexmedetomidine (0.3-10.0 μg), and mixtures of two doses of ketamines (30 or 100 μg) with different doses of morphine or dexmedetomidine for fixed-dose analysis. Results: Neither racemic ketamine nor its enantiomers alone had a significant effect on the tail-flick test, with the exception of the highest dose of racemic ketamine, which caused motor impairment. Morphine and dexmedetomidine each produced dose-dependent antinociception, with ED 50 of 1.7 μg (95% confidence interval: 1.04-2.32) and 4.85 μg (3.96-5.79), respectively. A low dose (30 μg) of racemic ketamine or its enantiomers did not influence the ED 50 of morphine significantly. Coadministration of 100 μg racemic ketamine or S(+)-ketamine, but not R(-)-ketamine, significantly enhanced and prolonged the antinociceptive effect of morphine. Both doses of racemic ketamine or its isomers significantly decreased the ED 50 value for dexmedetomidine, although the higher dose of racemic or S(+)-ketamine had the highest potency. One-hundred micrograms of racemic ketamine or S(+)-ketamine also prolonged the effects of dexmedetomidine. Conclusions: These data indicate that racemic ketamine and S(+)-ketamine, but not R(-)-ketamine, exhibit similar effectiveness in potentiating the antinociceptive effects of both morphine and dexmedetomidine.

Original languageEnglish
Pages (from-to)231-241
Number of pages11
JournalAnesthesiology
Volume93
Issue number1
Publication statusPublished - Jul 2000

Fingerprint

Dexmedetomidine
Ketamine
Morphine
Tail

Keywords

  • Adrenoceptor
  • NMDA antagonist
  • Opioid
  • Pain
  • Spinal

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats. / Joó, Gabriella; Horváth, G.; Klimscha, Walter; Kékesi, G.; Dobos, I.; Szikszay, Margit; Benedek, G.

In: Anesthesiology, Vol. 93, No. 1, 07.2000, p. 231-241.

Research output: Contribution to journalArticle

@article{365528adf7524b2793dc75a7f56f4aa7,
title = "The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats",
abstract = "Background: The spinal administration of some N-methyl-D-aspartate receptor antagonists results in antinociception and potentiates the effects of opioids and α 2-adrenoceptor agonists, but ketamine and its enantiomers have not been examined. The present study investigated the interactions of racemic ketamine, R(-)-ketamine and S(+)-ketamine with morphine and with dexmedetomidine. Methods: Intrathecal catheters were implanted into male Wistar rats. Three days later, the acute nociceptive sensitivity was assessed using the tail-flick test. Analgesic latencies were converted to the percentage maximum possible effect. The dose that yielded 50{\%} of the maximum possible effect (ED 50) and dose-response and time-course curves were determined for the ketamines (30-300 μg), morphine (0.13.0 μg), dexmedetomidine (0.3-10.0 μg), and mixtures of two doses of ketamines (30 or 100 μg) with different doses of morphine or dexmedetomidine for fixed-dose analysis. Results: Neither racemic ketamine nor its enantiomers alone had a significant effect on the tail-flick test, with the exception of the highest dose of racemic ketamine, which caused motor impairment. Morphine and dexmedetomidine each produced dose-dependent antinociception, with ED 50 of 1.7 μg (95{\%} confidence interval: 1.04-2.32) and 4.85 μg (3.96-5.79), respectively. A low dose (30 μg) of racemic ketamine or its enantiomers did not influence the ED 50 of morphine significantly. Coadministration of 100 μg racemic ketamine or S(+)-ketamine, but not R(-)-ketamine, significantly enhanced and prolonged the antinociceptive effect of morphine. Both doses of racemic ketamine or its isomers significantly decreased the ED 50 value for dexmedetomidine, although the higher dose of racemic or S(+)-ketamine had the highest potency. One-hundred micrograms of racemic ketamine or S(+)-ketamine also prolonged the effects of dexmedetomidine. Conclusions: These data indicate that racemic ketamine and S(+)-ketamine, but not R(-)-ketamine, exhibit similar effectiveness in potentiating the antinociceptive effects of both morphine and dexmedetomidine.",
keywords = "Adrenoceptor, NMDA antagonist, Opioid, Pain, Spinal",
author = "Gabriella Jo{\'o} and G. Horv{\'a}th and Walter Klimscha and G. K{\'e}kesi and I. Dobos and Margit Szikszay and G. Benedek",
year = "2000",
month = "7",
language = "English",
volume = "93",
pages = "231--241",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats

AU - Joó, Gabriella

AU - Horváth, G.

AU - Klimscha, Walter

AU - Kékesi, G.

AU - Dobos, I.

AU - Szikszay, Margit

AU - Benedek, G.

PY - 2000/7

Y1 - 2000/7

N2 - Background: The spinal administration of some N-methyl-D-aspartate receptor antagonists results in antinociception and potentiates the effects of opioids and α 2-adrenoceptor agonists, but ketamine and its enantiomers have not been examined. The present study investigated the interactions of racemic ketamine, R(-)-ketamine and S(+)-ketamine with morphine and with dexmedetomidine. Methods: Intrathecal catheters were implanted into male Wistar rats. Three days later, the acute nociceptive sensitivity was assessed using the tail-flick test. Analgesic latencies were converted to the percentage maximum possible effect. The dose that yielded 50% of the maximum possible effect (ED 50) and dose-response and time-course curves were determined for the ketamines (30-300 μg), morphine (0.13.0 μg), dexmedetomidine (0.3-10.0 μg), and mixtures of two doses of ketamines (30 or 100 μg) with different doses of morphine or dexmedetomidine for fixed-dose analysis. Results: Neither racemic ketamine nor its enantiomers alone had a significant effect on the tail-flick test, with the exception of the highest dose of racemic ketamine, which caused motor impairment. Morphine and dexmedetomidine each produced dose-dependent antinociception, with ED 50 of 1.7 μg (95% confidence interval: 1.04-2.32) and 4.85 μg (3.96-5.79), respectively. A low dose (30 μg) of racemic ketamine or its enantiomers did not influence the ED 50 of morphine significantly. Coadministration of 100 μg racemic ketamine or S(+)-ketamine, but not R(-)-ketamine, significantly enhanced and prolonged the antinociceptive effect of morphine. Both doses of racemic ketamine or its isomers significantly decreased the ED 50 value for dexmedetomidine, although the higher dose of racemic or S(+)-ketamine had the highest potency. One-hundred micrograms of racemic ketamine or S(+)-ketamine also prolonged the effects of dexmedetomidine. Conclusions: These data indicate that racemic ketamine and S(+)-ketamine, but not R(-)-ketamine, exhibit similar effectiveness in potentiating the antinociceptive effects of both morphine and dexmedetomidine.

AB - Background: The spinal administration of some N-methyl-D-aspartate receptor antagonists results in antinociception and potentiates the effects of opioids and α 2-adrenoceptor agonists, but ketamine and its enantiomers have not been examined. The present study investigated the interactions of racemic ketamine, R(-)-ketamine and S(+)-ketamine with morphine and with dexmedetomidine. Methods: Intrathecal catheters were implanted into male Wistar rats. Three days later, the acute nociceptive sensitivity was assessed using the tail-flick test. Analgesic latencies were converted to the percentage maximum possible effect. The dose that yielded 50% of the maximum possible effect (ED 50) and dose-response and time-course curves were determined for the ketamines (30-300 μg), morphine (0.13.0 μg), dexmedetomidine (0.3-10.0 μg), and mixtures of two doses of ketamines (30 or 100 μg) with different doses of morphine or dexmedetomidine for fixed-dose analysis. Results: Neither racemic ketamine nor its enantiomers alone had a significant effect on the tail-flick test, with the exception of the highest dose of racemic ketamine, which caused motor impairment. Morphine and dexmedetomidine each produced dose-dependent antinociception, with ED 50 of 1.7 μg (95% confidence interval: 1.04-2.32) and 4.85 μg (3.96-5.79), respectively. A low dose (30 μg) of racemic ketamine or its enantiomers did not influence the ED 50 of morphine significantly. Coadministration of 100 μg racemic ketamine or S(+)-ketamine, but not R(-)-ketamine, significantly enhanced and prolonged the antinociceptive effect of morphine. Both doses of racemic ketamine or its isomers significantly decreased the ED 50 value for dexmedetomidine, although the higher dose of racemic or S(+)-ketamine had the highest potency. One-hundred micrograms of racemic ketamine or S(+)-ketamine also prolonged the effects of dexmedetomidine. Conclusions: These data indicate that racemic ketamine and S(+)-ketamine, but not R(-)-ketamine, exhibit similar effectiveness in potentiating the antinociceptive effects of both morphine and dexmedetomidine.

KW - Adrenoceptor

KW - NMDA antagonist

KW - Opioid

KW - Pain

KW - Spinal

UR - http://www.scopus.com/inward/record.url?scp=0033916838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033916838&partnerID=8YFLogxK

M3 - Article

VL - 93

SP - 231

EP - 241

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 1

ER -